Premium
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model
Author(s) -
Tan Lijun,
Wang Weimin,
He Gong,
Kuick Rork D.,
Gossner Gabrielle,
Kueck Angela S.,
Wahl Heather,
Opipari Anthony W.,
Liu J. Rebecca
Publication year - 2016
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29793
Subject(s) - resveratrol , in vivo , cisplatin , ovarian cancer , apoptosis , autophagy , medicine , cancer research , pharmacology , cancer , biology , chemotherapy , biochemistry , microbiology and biotechnology
BACKGROUND Resveratrol inhibits the growth of ovarian carcinoma cells in vitro through the inhibition of glucose metabolism and the induction of both autophagy and apoptosis. In the current study, we investigated the metabolic and therapeutic effects of resveratrol in vivo. METHODS A fluorescent xenograft mouse model of ovarian cancer was used. Mice were treated with cisplatin, resveratrol, or vehicle alone. Tumor burden was assessed using whole‐body imaging. The effect of resveratrol on glucose uptake in vivo was determined using micro‐positron emission tomography scanning. To determine whether resveratrol could inhibit tumor regrowth, tumor‐bearing mice were treated with cisplatin followed by either daily resveratrol or vehicle. Autophagic response in resected tumors taken from mice treated with resveratrol was examined by transmission electron microscopy. Glycolysis and mitochondrial respiration in ovarian tumor cells after treatment with resveratrol was assessed. RESULTS Mice treated with resveratrol and cisplatin were found to have a significantly reduced tumor burden compared with control animals ( P <.001). Resveratrol‐treated mice demonstrated a marked decrease in tumor uptake of glucose compared with controls. After treatment with cisplatin, “maintenance” resveratrol resulted in the suppression of tumor regrowth compared with mice receiving vehicle alone ( P <.01). Tumors resected from mice treated with resveratrol exhibited autophagosomes consistent with the induction of autophagy. Treatment with resveratrol inhibited glycolytic response in ovarian tumor cells with high baseline glycolytic rates. CONCLUSIONS Treatment with resveratrol inhibits glucose uptake and has a significant antineoplastic effect in a preclinical mouse model of ovarian cancer. Resveratrol treatment suppresses tumor regrowth after therapy with cisplatin, suggesting that this agent has the potential to prolong disease‐free survival. Cancer 2016;122:722–729. © 2015 American Cancer Society .